Spots Global Cancer Trial Database for Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
Official Title:
Study ID: NCT00189683
Conditions
Study Description
Brief Summary: To compare maintenance chemotherapy with Xeloda to control after best response with first line chemotherapy in advanced colorectal cancer. Main endpoint is progression free survival. A total of 300 patients will be included.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
AERO, Creteil, , France
Contact Details
Name: Elizabeth Fabre-Guillevin, MD
Affiliation: AERO
Role: PRINCIPAL_INVESTIGATOR
Name: Eric Van Cutsem, MD
Affiliation: BGDO
Role: PRINCIPAL_INVESTIGATOR
Name: Marc Polus, MD
Affiliation: BGDO
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
